AUS
NZ
UK
CA
USA
IND
Vita Life Sciences Limited (ASX:VLS) recently announced a dividend payment of A$0.035 per share, scheduled for the 4th of October. This dividend payment will yield an attractive 3.9%, adding to the overall returns for shareholders. For income-focused investors, this makes Vita Life Sciences a stock worth considering, especially in a low-interest-rate environment.
Solid Earnings Coverage for Dividend Payments
A high dividend yield is appealing, but it’s crucial that the payout is sustainable over the long term. In Vita Life Sciences’ case, the recent dividend was comfortably covered by the company’s earnings, indicating that the business is retaining a significant portion of its profits for reinvestment. This reinvestment could drive future growth, further solidifying the company’s ability to maintain or even increase its dividend payments.
Looking ahead, analysts expect the company’s earnings per share (EPS) to grow by an impressive 43.4% over the next 12 months. If this growth materializes, the payout ratio could stabilize around 44%, a level that suggests the dividend is likely to be sustainable going forward.
Dividend Volatility: A Cautionary Note
Despite the attractive dividend yield and earnings coverage, it’s important to note that Vita Life Sciences has a history of dividend volatility. Over the last decade, the company has cut its dividend at least once, which can be a red flag for income investors seeking stability. However, the annual dividend has increased from A$0.04 in 2014 to A$0.09 in the most recent fiscal year, representing a compound annual growth rate (CAGR) of approximately 8.4% over that period. While this growth is promising, the history of cuts means that caution is warranted when relying on this stock solely for income.
